Formela Jean Francois
SEC-identified person · CIK 1030575 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Korro Bio, Inc. KRRO | Director | filed 2023 - 2026 |
| Imagenebio, Inc. IMA | Director | filed 2021 - 2024 |
| Intellia Therapeutics, Inc. NTLA | Director | filed 2016 - 2022 |
| Translate Bio, Inc. TBIO | Director | filed 2018 - 2021 |
| Spero Therapeutics, Inc. SPRO | Director | filed 2017 - 2021 |
| Zyla Life Sciences ZCOR | Director | filed 2014 - 2014 |
| Oruka Therapeutics, Inc. ORKA | Director | filed 2009 - 2012 |
| Horizon Therapeutics Public Ltd Co HZNP | Director | filed 2011 - 2012 |
| Achillion Pharmaceuticals INC ACHN | Director | filed 2006 - 2007 |
| SGX Pharmaceuticals, INC. sgxp | Director | filed 2006 - 2007 |
| Nxstage Medical, Inc. NXTM | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.